DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer-Reference-Cited by-同舟云学术

DDX5 mRNA-targeting antisense oligonucleotide as a new promising therapeutic in combating castration-resistant prostate cancer

Published:2023-02 Issue:2 Volume:31 Page:471-486
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Le Thi Khanh^ORCID,Cherif Chaïma,Omabe Kenneth,Paris Clément,Lannes François,Audebert Stéphane,Baudelet Emilie,Hamimed Mourad,Barbolosi Dominique,Finetti Pascal,Bastide Cyrille,Fazli Ladan,Gleave Martin,Bertucci François,Taïeb David,Rocchi Palma^ORCID

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference55 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA. Cancer J. Clin.,2018

2. The hallmarks of castration-resistant prostate cancers;Katsogiannou;Cancer Treat. Rev.,2015

3. Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitro;Rocchi;BJU Int.,2006

4. Increased Hsp27 after androgen ablation facilitates androgen-independent progression in prostate cancer via signal transducers and activators of transcription 3-mediated suppression of apoptosis;Rocchi;Cancer Res.,2005

5. Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer;Rocchi;Cancer Res.,2004

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Embryonic microenvironment suppresses YY1 and YY1-related genes in prostate cancer stem cells;Pathology - Research and Practice;2024-08

2. Nicotinamide riboside Induced Energy Stress and Metabolic Reprogramming in BEAS-2B Cells;Chemical Research in Toxicology;2024-07-11

3. Clinically and orally compatible formulation-manufactured DDX5 (p68)-targeting molecular glue FL118 products exhibit low toxicity but high efficacy against human cancer;Journal of Pharmaceutical Analysis;2024-05

4. Cellular senescence in cancer: molecular mechanisms and therapeutic targets;MedComm;2024-04-24

5. CRISPR editing to mimic porphyria combined with light: A new preclinical approach for prostate cancer;Molecular Therapy: Oncology;2024-03